Opioids are the recommended treatment of choice for cancer pain at the end of life according to all major guidelines, but Black and Hispanic patients are 13% and 11% less likely than their White counterparts, respectively, to obtain prescription opioids for cancer-related pain at the end of life, researchers reported in the Journal of Clinical Oncology.